Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute ...

By Dr. Liji Thomas, MD Study reveals how the JAK inhibitor lowers ACE2 expression and viral entry in individuals with a ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

Diagnosing simultaneous infections of multiple respiratory viruses is challenging. Researchers from Korea have now addressed ...

Faster post-COVID-19 recovery is observed after infection with the Omicron vs earlier variants, regardless of vaccination status.

The following is a summary of “Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States,” published in ...

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.

The National Institute of Mental Health has awarded a significant grant of $1.5 million to Jianyang Du, PhD, of the ...

The cumulative incidence of postacute sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (PASC) during the first year after infection decreased over the course of the ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache, nausea ...